Abstract

Pre-clinical SCS studies have previosuly demonstated that neural activity, and in turn, perception of pain can be robustly modulated via the stimulation of different neuronal targets (e.g. dorsal Horn, dorsal column).1,2 Stimulation of multiple simultaneous targets via the dual use of sub- and supra-perception-based SCS modalities (i.e. combination therapy) may therefore be able to enhance pain relief outcomes. In support of this postulate, positive outcomes when using combination therapy in SCS-implanted patients have now been recently reported.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call